Who should receive MCV4 vaccine?
• All persons 11-18 years of age. • Persons at increased risk for meningococcal disease aged 2-55 years. • Persons vaccinated at 2-6 years of age should be revaccinated after 3 years. • Persons vaccinated at >7 years and who are at prolonged risk should be revaccinated after 5 years. Persons at prolonged increased risk for meningococcal disease include: • People with immune system disorders including removed or damaged spleen and complement component deficiencies. Persons who have prolonged exposure such as laboratory personnel who are routinely exposed to the meningococcus. • Travelers to or residents of regions where meningococcal disease is at increased risk such as certain parts of Africa and Mecca during the Hajj, and other locations where meningococcal disease is common. • If at risk, MPSV4 can likely be safely given to pregnant women; there is no data for MCV4 given during pregnancy. Who should not receive the meningococcal vaccines? • People who had a serious reaction to a prev
